"T2/FLAIR:"
"DWI: normal 6,17"
"SWI: normal 17"
"T1 C+ (Gd):"
"MR angiogram: normal 6,17"
"T2: hyperintense longitudinally extensive spinal cord lesion(s), often pericentrally located, present in half of all patients 1-6,13,14,17,19"
"T1 C+ (Gd): may have contrast-enhancement, which is usually leptomeningeal or of the central canal 1-6,13,14,17"
"T2: hyperintense longitudinally extensive spinal cord lesion(s), often pericentrally located, present in half of all patients 1-6,13,14,17,19"
"The key marker is the GFAP antibody, which has a higher positive predictive value when present in the CSF than in the serum 5. Additionally, CSF will often have an inflammatory phenotype, with high protein and a pleocytosis 1-6. Co-existing autoantibodies (e.g. NMDAR antibody, AQP4 antibody) may also be present, especially in patients with ovarian teratoma 1-6,11,17."
Expected headings
"Associations"
"Brain"
"Spinal cord"
"Given the rarity of the condition, epidemiological data pertaining to autoimmune GFAP astrocytopathy are not well established. Based on existing case series-level data, it tends to manifest in middle-aged adults, but can also affect paediatric patients 12, and there are conflicting reports regarding any sex preponderance 1,13,17,21."
"Autoimmune GFAP astrocytopathy has a broad clinical neuropsychiatric and temporal spectrum 1-6,8. The most common phenotypical syndromes are those of meningoencephalitis or meningoencephalomyelitis 1-6,8,21, which can manifest over an acute, subacute, or less commonly, a chronic time-frame 4,8. It is usually (~80%) monophasic 17."
"Within those syndromes, a wide range of clinical features may be present, the most common of which include 1-6,8,17,21,22:"
"hyperintense, diffuse, confluent, periventricular white matter lesions (present in up to 75% of cases) 1-6,11,17, sometimes extending into or otherwise involving the cortex, centrum semiovale, thalami (especially posteriorly), basal ganglia, and/or brainstem 1,3,11,13,17"
"characteristic (present in up to ~50% of cases) linear, perivascular pattern of contrast-enhancement extending radially from the periventricular surface and through the cerebral white matter, although can also be seen extending through the thalami and basal ganglia 1-6,11,12,18,19,21"
"other less characteristic, but possible, patterns of enhancement include leptomeningeal, punctate, nodular, or periependymal 1,2,4-6,11,13,17"
"T2: hyperintense longitudinally extensive spinal cord lesion(s), often pericentrally located, present in half of all patients 1-6,13,14,17,19"
"Autoimmune GFAP astrocytopathy is typically steroid-responsive 1-6. In cases that are steroid-refractory, often in the setting of concurrent underlying malignancy or another co-existing autoantibody, there may be response to other immunosuppressive agents (e.g. rituximab, mycophenolate mofetil, azathioprine, cyclophosphamide, intravenous immunoglobulin) 5."
"movement disorders (e.g. tremor, chorea, myoclonus)"
"bulbar symptoms (e.g. dysphagia)"
"psychiatric symptoms (e.g. psychosis)"
"in paediatric patients, the pons, thalami and basal ganglia may be more likely to be affected 12,16"
"T1 spin echo (SE) C+ (Gd) may be more sensitive than T1 gradient echo (GE) C+ (Gd) 18"